Post-transplantation cyclophosphamide for graft-versus- host disease prophylaxis in multiple myeloma patients who underwent allogeneic hematopoietic cell transplantation: first comparison by Donor Type. A study from the chronic malignancies working party of the European Society for Blood and Marrow Transplantation - Sahebi, Firoozeh; Eikema, Dirk-Jan; Koster, Linda; Kroger, Nicolaus; Meijer, Ellen; van Doesum, Jaap A.; Rovira, Montserrat; Koc, Yener; Angelucci, Emanuele; Blaise, Didier; Sammassimo, Simona; McDonald, Andrew; et al. (Transplantation and cellular therapy, 2021)
Gesehen am 03.03.2022